BMY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bristol-Myers Squibb Co

Watchlist Manager

Watchlist

Price: 64.665 USD -1.23%

Market Cap: $132.1B

	Bristol-Myers Squibb Co NYSE:BMY	US
	SoFi Technologies Inc MIL:1SOFI	US
	St James's Place PLC OTC:STJPF	UK
	Helios Technologies Inc NYSE:HLIO	US
K	Kontoor Brands Inc SWB:3KO	US
	Knowledge Atlas Technology JSC Ltd OTC:KATJF	CN

Profitability Summary

Bristol-Myers Squibb Co's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

72%

Strong 3Y Average Gross Margin

75%

Declining Gross Margin

77% > 72%

Exceptional Operating Margin

35%

Sustainable 3Y Average Operating Margin

29%

Operating Margin is Increasing

24% > 35%

Healthy Net Margin

19%

Low 3Y Average Net Margin

Net Margin is Increasing

18% > 19%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

30%

Free Cash Flow Margin is Increasing

24% > 34%

Exceptional ROE

82%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

12% > 49%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.